Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model-Reference-Cited by-同舟云学术

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model

Published:2022-08-06 Issue:10 Volume:113 Page:3547-3557
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Hanada Kako¹,Fukasawa Kunpei¹,Hinata Hiroki¹,Imai Shú¹,Takayama Kentaro²³,Hirai Hideyo¹,Ohfusa Rina²,Hayashi Yoshio²,Itoh Fumiko¹^ORCID

Affiliation:

1. Laboratory of Stem Cell Regulation Tokyo University of Pharmacy and Life Sciences Tokyo Japan

2. Department of Medicinal Chemistry Tokyo University of Pharmacy and Life Sciences Tokyo Japan

3. Department of Environmental Biochemistry Kyoto Pharmaceutical University Kyoto Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15491

Reference38 articles.

1. Understanding the mechanisms and treatment options in cancer cachexia

2. The role of systemic inflammation in cancer‐associated muscle wasting and rationale for exercise as a therapeutic intervention;Cole CL;JCSM Clin Rep,2018

3. Definition and classification of cancer cachexia: an international consensus

4. Cancer-associated cachexia

5. Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance;Frontiers in Pharmacology;2024-07-19

2. Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome;Current Oncology Reports;2024-05-21

3. Annual banned‐substance review 16^th edition—Analytical approaches in human sports drug testing 2022/2023;Drug Testing and Analysis;2023-11-20

4. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management;Biochemical Pharmacology;2023-10

5. Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions;Metabolites;2023-09-20